The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products ... by Eli Lilly in 1982 as Humulin.

Before Merilog, the FDA has given the go-ahead to two biosimilars of Sanofi's basal insulin product Lantus (insulin glargine) – Viatris' Semglee and Eli ... of their older products and the ...

Maine Attorney General Aaron Frey announced a settlement agreement Tuesday with Sanofi-Aventis U.S. following scrutiny over the company’s pricing of insulin products. Under the settlement ...

Both of these products quickly became blockbusters and, along with drugs from Novo Nordisk, dominate the market. All of this has helped Lilly's revenue climb in the double digits in recent ...

Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ... Authority approved the insulin glargine injection ...

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...